Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG Topic: Neurology

Neurology is the field of medicine concerning the diagnosis, delineation, and treatment of disorders and diseases of the nervous system. Common neurological disorders include depression, epilepsy, anxiety, sleep disorders, and schizophrenia. Examples of common neurological diseases include Parkinson's, Huntington's, and Alzheimer's.

Request a consultation







Leading Experts: Neurology

What is a GLG Leader?
Joseph Friedman, MD
Associate Professor and Director
MOUNT SINAI SCHOOL OF MEDICINE

Joseph Friedman, MD, is the Director of Clinical Neuroscience Center and Associate Professor of Psychiatry at the Mount Sinai School of Medicine in New York. He has expertise in the treatment of schizophrenia and Alzheimer's disease and is noted for clinical trials work in schizophrenia and Alzheimer's...

Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.

Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...

B. Michael Silber, PHD, Chief of Drug Discovery R & D , UNIVERSITY OF CALIFORNIA SAN FRANCISCOB. Michael Silber, PHD
Chief of Drug Discovery R & D
UNIVERSITY OF CALIFORNIA SAN FRANCISCO

Michael Silber, PhD, is Chief of Drug Discovery R & D and Adjunct Professor of Neurology and Biopharmaceutical Sciences, Institute for Neurodegenerative Diseases, at UCSF Medical School. He has over 25 years of expertise in all aspects of Pharma and Biotech R & D and API and biologics manufacturing,...

Jason Campagna, MD,PhD, Director of Clinical Quality and Analytics, COTTAGE HEALTH SYSTEMJason Campagna, MD,PhD
Director of Clinical Quality and Analytics
COTTAGE HEALTH SYSTEM

Jason Campagna, MD, PhD, is an Anesthesiologist in Santa Barbara, California and the Director of Center for Clinical Quality and Analytics at Cottage Health System. He also holds a faculty appointment at Neuroscience Research Institute at UC Santa Barbara, and serves as the Director of Center for Applied...

Mark Capriani, MBA
President and Chief Executive Officer
AciesHealth

Mark Capriani, MBA, is the President and Chief Executive Officer of AciesHealth, a specialty pharmaceutical company in Pennsylvania. He has over 15 years of experience in pharmaceutical industry including biotech, branded and multi source pharmaceuticals, consumer products, device, and wound and burn...

View All GLG Leaders in Healthcare

GLG NewsSM Analysis: Neurology(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
COPAXONE from the START of MS | 04-24-2008
Author: Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.

Copaxone has become the leading treatment for relapsing remitting MS in the US.  The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further.

Abbott Targets Adult ADHD with Nicotinic Drug, Shows Strong CNS Pipeline | 05-13-2008
Author: GLG Expert Contributor

Abbott’s Neuronal Nicotinic Receptor (NNR) partial agonist platform is an innovative target for ADHD and potentially other CNS disorders.  The Phase II data on ABT-089 suggests efficacy for adult ADHD with good safety/tolerability.  NNRs will not have the kind of effect size seen with stimulants...

Alzheimer Finding May Increase Bid Under Rising Vitamin E Prices | 04-29-2008
Analysis of: Vitamin E May Up Alzheimer's Survival | www.webmd.com
Author: GLG Expert Contributor

The American Academy of Neurology announced that Vitamin E holds substantial health benefits for Alzheimer's sufferers.  These findings may increase demand for supplemental Vitamin E.  Vitamin E producers have recently increased prices, primarily, due to exploding feedstock demand.  In...

View All GLG News in Healthcare

GLG InstituteSM Seminars: Neurology(?)

 
Recent Seminars
GLGi: Alzheimer’s Disease
San Francisco, 04-22-2008
GLGi: Multiple Sclerosis
New York, 04-09-2008
GLGi: Multiple Sclerosis
Boston, 04-10-2008
View All View all GLG InstituteSM Seminars in in Healthcare

Quick Facts about GLG

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics